IMAC Holdings' Q1 Loss Widens to $2.2M Amid Debt & Equity Raises

TL;DR

**IMAC Holdings is burning cash and piling on debt; steer clear unless you're a high-risk speculator.**

AI Summary

IMAC Holdings, Inc. reported a net loss of $2.2 million for the three months ended March 31, 2025, a significant increase from the $1.5 million net loss in the prior-year period. Revenue figures were not explicitly detailed in the provided excerpt, but the increased net loss suggests operational challenges or higher expenses. Key business changes include the issuance of a 40% OID Promissory Note and a 10% OID Promissory Note during the first quarter of 2025, indicating reliance on debt financing. The company also engaged in a Common Stock Purchase Agreement and issued various series of preferred stock (Series C-One, C-Two, D, E, F, G) and common stock purchase warrants, reflecting ongoing capital-raising efforts. Risks are heightened by the substantial net loss and the issuance of high-interest promissory notes, which could strain future liquidity. The strategic outlook appears focused on securing capital to sustain operations, as evidenced by the diverse financing activities.

Why It Matters

IMAC Holdings' widening net loss and reliance on high-interest debt and dilutive equity raises signal significant financial distress, impacting investor confidence and potentially future growth. For employees, this could mean job insecurity or limited growth opportunities as the company prioritizes survival. Customers might face service disruptions if financial instability affects operational capacity. In the competitive landscape of specialty outpatient facilities, IMAC's struggles could allow more stable competitors to gain market share, further marginalizing the company.

Risk Assessment

Risk Level: high — The risk level is high due to a net loss of $2.2 million for Q1 2025, an increase from $1.5 million in Q1 2024, indicating deteriorating financial performance. Furthermore, the issuance of a 40% OID Promissory Note and a 10% OID Promissory Note in Q1 2025 highlights a reliance on expensive debt financing, which could lead to significant interest burdens and potential default risks.

Analyst Insight

Investors should exercise extreme caution and consider divesting from IMAC Holdings, Inc. given the escalating net losses and the company's reliance on dilutive equity and high-interest debt financing. New investors should avoid initiating a position until there is clear evidence of improved profitability and a sustainable capital structure.

Key Numbers

• $2.2M — Net Loss (Increased from $1.5M in Q1 2024, indicating worsening financial performance.)
• 40% — OID Promissory Note Interest (High-interest debt issued in Q1 2025, signaling financial strain.)
• 10% — OID Promissory Note Interest (Another high-interest debt instrument issued in Q1 2025.)
• Q1 2025 — Reporting Period (Period covered by the 10-Q filing, showing recent financial results.)
• 700K — Increase in Net Loss (Difference between Q1 2025 and Q1 2024 net losses ($2.2M - $1.5M).)

Key Players & Entities

• IMAC Holdings, Inc. (company) — filer of the 10-Q
• $2.2 million (dollar_amount) — net loss for Q1 2025
• $1.5 million (dollar_amount) — net loss for Q1 2024
• 40% OID Promissory Note (dollar_amount) — debt instrument issued in Q1 2025
• 10% OID Promissory Note (dollar_amount) — debt instrument issued in Q1 2025
• Common Stock Purchase Agreement (company) — financing activity in Q1 2025
• Series C-One Preferred Stock (company) — equity instrument issued by IMAC Holdings
• Series G Preferred Stock (company) — equity instrument issued by IMAC Holdings
• March 31, 2025 (date) — end of the reporting period
• July 1, 2025 (date) — filing date of the 10-Q

FAQ

Risk Factors

• Increased Net Loss [high — financial]: The company reported a net loss of $2.2 million for Q1 2025, a significant increase from the $1.5 million net loss in the prior-year period. This $700,000 increase in losses suggests deteriorating operational performance or escalating costs without a corresponding revenue increase.
• Reliance on High-Interest Debt [high — financial]: IMAC Holdings issued a 40% OID Promissory Note and a 10% OID Promissory Note in Q1 2025. These high-interest debt instruments indicate a potential strain on future liquidity and increased financial risk due to substantial interest obligations.
• Ongoing Capital Raising Activities [medium — financial]: The company engaged in a Common Stock Purchase Agreement and issued multiple series of preferred stock (Series C-One, C-Two, D, E, F, G) along with common stock purchase warrants. This pattern of diverse financing activities highlights a continuous need for capital, potentially signaling underlying financial instability.

Industry Context

IMAC Holdings operates in the specialty outpatient facilities sector, which includes various healthcare services. This industry is characterized by regulatory oversight, evolving patient care models, and competition from both specialized clinics and larger healthcare systems. Trends include a focus on value-based care and increasing adoption of telehealth services.

Regulatory Implications

As a healthcare provider, IMAC Holdings is subject to stringent regulations, including those related to patient privacy (HIPAA), billing practices, and healthcare facility standards. Non-compliance can lead to significant fines, reputational damage, and operational disruptions.

What Investors Should Do

1. Monitor cash burn and liquidity runway.
2. Analyze the terms of new debt and equity issuances.
3. Seek clarity on revenue drivers and operational improvements.

Key Dates

• 2025-03-31: End of Q1 2025 — Reporting period for the 10-Q, revealing a net loss of $2.2 million and significant debt financing activities.
• 2025-01-01: Beginning of Q1 2025 — Period during which the company issued a 40% OID Promissory Note and a 10% OID Promissory Note, alongside preferred stock and warrants.
• 2025-07-01: Filing Date of 10-Q — Indicates the company's latest official financial disclosure to the SEC.

Glossary

OID Promissory Note

A promissory note where the original issue discount (OID) is factored into the principal amount, effectively increasing the yield to maturity. It's a form of debt financing. (IMAC Holdings issued notes with OID at high interest rates (40% and 10%), indicating significant borrowing costs and potential financial distress.)

Preferred Stock

A class of ownership in a corporation that has a higher claim on the assets and earnings than common stock. It typically does not carry voting rights but may offer fixed dividends. (The issuance of multiple series of preferred stock (C-One, C-Two, D, E, F, G) signifies capital-raising efforts, diluting existing equity and potentially carrying specific rights or preferences.)

Common Stock Purchase Warrants

A security that gives the holder the right, but not the obligation, to purchase a company's stock at a specified price within a certain timeframe. (Issued alongside other securities, these warrants represent potential future dilution of common stock and are part of the company's capital-raising strategy.)

10-Q

A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance and condition. (This document provides the latest financial details for IMAC Holdings, Inc., including its net loss and financing activities for the first quarter of 2025.)

Year-Over-Year Comparison

The first quarter of 2025 shows a worsening financial performance for IMAC Holdings, Inc., with a net loss of $2.2 million compared to $1.5 million in the same period last year, representing a $700,000 increase in losses. This deterioration occurred alongside aggressive capital-raising activities, including the issuance of high-interest OID promissory notes and multiple series of preferred stock, signaling increased financial risk and a potential struggle to achieve profitability.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on July 1, 2025 regarding IMAC Holdings, Inc. (BACK).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR